» Articles » PMID: 38891820

Macrophage Polarization and Functions in Pathogenesis of Chronic Obstructive Pulmonary Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38891820
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD), the major leading cause of mortality worldwide, is a progressive and irreversible respiratory condition characterized by peripheral airway and lung parenchymal inflammation, accompanied by fibrosis, emphysema, and airflow limitation, and has multiple etiologies, including genetic variance, air pollution, and repetitive exposure to harmful substances. However, the precise mechanisms underlying the pathogenesis of COPD have not been identified. Recent multiomics-based evidence suggests that the plasticity of alveolar macrophages contributes to the onset and progression of COPD through the coordinated modulation of numerous transcription factors. Therefore, this review focuses on understanding the mechanisms and functions of macrophage polarization that regulate lung homeostasis in COPD. These findings may provide a better insight into the distinct role of macrophages in COPD pathogenesis and perspective for developing novel therapeutic strategies targeting macrophage polarization.

Citing Articles

PGAM5 Modulates Macrophage Polarization, Aggravating Inflammation in COPD via the NF-κB Pathway.

Zheng Y, Wang Y, Li J, Zheng S, Zhang L, Li Q Int J Chron Obstruct Pulmon Dis. 2025; 20:551-564.

PMID: 40078929 PMC: 11897911. DOI: 10.2147/COPD.S492627.


Research advances in polyphenols from Chinese herbal medicine for the prevention and treatment of chronic obstructive pulmonary disease: a review.

Zhang Y, Wang L, Zeng J, Shen W Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40035820 DOI: 10.1007/s00210-025-03945-y.


Macrophage Polarization: Learning to Manage It 3.0.

Lampiasi N Int J Mol Sci. 2025; 26(1.

PMID: 39796166 PMC: 11719942. DOI: 10.3390/ijms26010311.


Epigenetic mechanisms of alveolar macrophage activation in chemical-induced acute lung injury.

Ahmad S, Nasser W, Ahmad A Front Immunol. 2024; 15:1488913.

PMID: 39582870 PMC: 11581858. DOI: 10.3389/fimmu.2024.1488913.

References
1.
Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

2.
Tan S, Krasnow M . Developmental origin of lung macrophage diversity. Development. 2016; 143(8):1318-27. PMC: 4852511. DOI: 10.1242/dev.129122. View

3.
ODonnell D, Laveneziana P . Dyspnea and activity limitation in COPD: mechanical factors. COPD. 2007; 4(3):225-36. DOI: 10.1080/15412550701480455. View

4.
Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View

5.
Keatings V, Collins P, Scott D, Barnes P . Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996; 153(2):530-4. DOI: 10.1164/ajrccm.153.2.8564092. View